Memorial Sloan Kettering Cancer Center at ASCO 2024

In the U.S.

Memorial Sloan Kettering Cancer Center (MSK) is proud to honor the work of our physician-scientists and researchers presenting at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting from May 31 - June 4 in Chicago.

Check back here throughout the five-day meeting for the latest updates, presentation highlights, news releases, and award recipients.

Schedule of MSK Presenters

Find out when MSK experts are presenting during the ASCO meeting.

Learn more

News Releases

ASCO 2024: Memorial Sloan Kettering Cancer Center Experts to Present Leading Edge Research at American Society of Clinical Oncology Annual Meeting

ASCO 2024: Memorial Sloan Kettering Cancer Center Experts Featured at American Society of Clinical Oncology Annual Meeting

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31–June 4, in Chicago.

ASCO 2024: Memorial Sloan Kettering Cancer Center Experts Receive Prestigious Awards from American Society of Clinical Oncology

Several Memorial Sloan Kettering Cancer Center (MSK) physician-scientists have been recognized by the American Society of Clinical Oncology (ASCO).

Editorial Features

Avoiding Surgery for HPV Throat Cancer May Be Possible for More Patients

Learn how HPV-related head and neck cancer can be treated with a sharply reduced radiation dose to prevent side effects, sometimes without surgery.

MSK ASCO 2024 Research Roundup: Practice-Changing Advances in Head and Neck Cancer, Tenosynovial Giant Cell Tumor, Kidney Cancer, Lung Cancer, and More

MSK physician-scientists presented breakthrough advances in new treatment approaches for several cancer types at the 2024 ASCO Annual Meeting.

MSK thoracic oncologist Robert Daly, MD, MBA is seen standing in a clinic hallway.

Cancer Care at Home: MSK Advances Lead the Field

Learn how new clinical trials at MSK are helping make cancer care at home a reality.

The 2024 ASCO sign hangs above a long hallway

Important Findings for Treating Rare Solid Tumors Reported at 2024 ASCO Meeting

Researchers from MSK presented promising studies on treating rare solid tumors including mesothelioma and three types of soft-tissue at the annual meeting of the American Society of Clinical Oncology.

Large letters that say ASCO promoting annual meeting in Chicago.

MSK Researchers Present Advances in Lung Cancer Treatment at 2024 ASCO Meeting

Read about advances in lung cancer treatment presented by MSK scientists at the 2024 ASCO meeting.

Four people who were successfully treated for rectal cancer in a clinical trial at Memorial Sloan Kettering are seen posing outdoors with the trial’s two principal investigators.

Rectal Cancer Disappears After Experimental Use of Immunotherapy, Now an FDA Designated Breakthrough Therapy

Rectal cancer patients saw their tumors disappear in a clinical trial involving immunotherapy at Memorial Sloan Kettering Cancer Center—without surgery, radiation, or chemotherapy.

Connect with MSK at #ASCO24

@MSKCancerCenter

Press Inquires

Members of the media interested in speaking with MSK experts, please contact:
Rebecca Williams
Manager, Media Relations
Memorial Sloan Kettering Cancer Center
williamr@mskcc.org

Request an appointment

Call 800-525-2225
Available Monday through Friday, 8 a.m. to 6 p.m. (Eastern time)

Changing how the world understands and treats cancer

Training the next generation of clinicians and scientists

We're here for you.

Make an appointment

Speak to a care advisor

We treat every type of cancer, including the most important one: yours.

Partner with us to treat your patient’s cancer.

CALL OUR DEDICATED CLINICIAN ACCESS NUMBER

Our mission: Ending cancer for life.

In the U.S.

Outside of the U.S.

Press Inquires